Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Makita, M. Suzuki, K. Nagai, M. Nishimura, Hokkaido COPD Cohort Study Group (Sapporo, Japan). Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 4721

Member's Comments

No comment yet.

Related content which might interest you: Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases Year: 2015 Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013 Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90 Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 FEV1/FVC agreement study between two different seasons Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Lung clearance index is increased in patients with COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Risk scores for predicting death in COPD patients Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Scintigraphic parameters in COPD patients Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 LATE-BREAKING ABSTRACT: Predictors of lung function decline in a cohort of subjects with severe asthma Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Determination of the existence of a correlation between lung function decline and changes in the COPD assessment test Source: International Congress 2014 – Clinical presentations Year: 2014 COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study Source: International Congress 2014 – Markers Year: 2014 CPOD and lung function parameters as predictors of mortality: Results from the Latin American PLATINO cohort study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 The effects of standard therapy for COPD patients on FEV1 are associated with lower score of the Goddard classification Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Correlation between red cell distribution width and disease severity and mortality in COPD patients Source: International Congress 2014 – COPD exacerbations Year: 2014